Public health surveillance · GISAID

GISAID

Global data-sharing initiative, not a commercial product, for rapid exchange of pathogen genomic sequences and metadata.

GISAID is a data-sharing initiative rather than a software product: it operates databases where laboratories worldwide submit genomic sequences and associated metadata for priority pathogens, including influenza, SARS-CoV-2, RSV, mpox, and arboviruses such as dengue and chikungunya. Access is governed by a Database Access Agreement rather than a purchase or subscription; any individual can register for free personal credentials after identifying themselves and agreeing to GISAID's data-sharing etiquette, which requires acknowledging the originating and submitting laboratories behind any data used. This access model, built to encourage rapid sharing during outbreaks while still crediting contributing labs, is what distinguishes GISAID from fully open public repositories with no attribution requirements. GISAID does not store restricted sequences, so anything submitted becomes available to all credentialed users. It is used by public health agencies, vaccine developers, and researchers who need near-real-time access to circulating pathogen genomic data during surveillance and outbreak response.

At a glance

Vendor GISAID
Pricing model Free
Free tier Yes
Deployment Cloud
Open source No
Best for Public health agencies and researchers needing near-real-time, attributed access to circulating pathogen genomic sequences.

Pricing

Free access after identity verification and agreement to GISAID's Database Access Agreement; it is an access-controlled data-sharing initiative, not a paid product.

Pricing has not been verified yet — see the vendor's site.

Features

  • Global genomic sequence and metadata database
  • Coverage of influenza, SARS-CoV-2, RSV, mpox, and arboviruses
  • Credentialed, identity-verified access model
  • Data-sharing etiquette with lab attribution requirements
  • No storage of restricted sequences
  • Rapid-sharing design for outbreak response
  • Free registration for individual researchers

Profile last reviewed September 21, 2026

Alternatives

GISAID in the index now

Related guides